16:42 , Jul 20, 2018 |  BC Week In Review  |  Company News

Novartis halts price increases, reports 2Q earnings

Novartis AG (NYSE:NVS; SIX:NOVN) announced on July 18 that it will suspend for the rest of the year price increases in the U.S. The pharma made the announcement in conjunction with the release of its 2Q18...
22:01 , Jul 19, 2018 |  BC Extra  |  Company News

Merck to tie price increases to inflation

Merck & Co. Inc. (NYSE:MRK) followed Pfizer Inc. (NYSE:PFE) and Novartis AG (NYSE:NVS; SIX:NOVN) in publicly responding to President Donald Trump's demands for voluntary price reductions. Merck said it will not increase the average net...
15:20 , Jul 19, 2018 |  BC Extra  |  Politics & Policy

HHS moving forward on rebate reforms

Two days after the public comment period ended for its drug pricing blueprint, HHS has signaled that it is moving forward with initiatives to regulate drug rebating practices. The HHS Office of the Inspector General (OIG)...
19:59 , Jul 18, 2018 |  BC Extra  |  Company News

Novartis halts price increases, reports 2Q earnings

Novartis AG (NYSE:NVS; SIX:NOVN) announced Wednesday that it will suspend for the rest of the year price increases in the U.S. The pharma made the announcement in conjunction with the release of its 2Q18 earnings. On...
21:16 , Jul 16, 2018 |  BC Extra  |  Politics & Policy

Biopharma, PBMs battle over HHS drug pricing blueprint

Trade associations representing drug manufacturers, PBMs, hospitals, insurance companies and pharmacies presented drastically differing diagnoses of, and prescriptions for the U.S. drug market in response to the Trump administration’s request for comments about its drug...
20:06 , Jul 11, 2018 |  BC Extra  |  Politics & Policy

Pfizer creates deadline for Trump drug plan

Pfizer Inc. (NYSE:PFE) Chairman and CEO Ian Read has turned President Donald Trump’s fury over drug price increases into an opportunity to create a de facto deadline for the Trump administration to implement its drug...
20:40 , Jul 10, 2018 |  BC Extra  |  Politics & Policy

Trump administration may go beyond drug price blueprint

Recent drug price increases are prompting the Trump administration to consider taking steps that go beyond the drug pricing blueprint it released in May, John O’Brien, adviser to the HHS secretary and deputy assistant secretary...
23:33 , Jul 9, 2018 |  BC Extra  |  Politics & Policy

Pain patients zero in on CDC guidelines, side effects

Chronic pain patients said that CDC guidelines and side effects of non-opioid medicines are the major hurdles to accessing effective treatments for their disease. The statements were made at an FDA Patient-Focused Drug Development (PFDD)...
22:53 , Jul 9, 2018 |  BC Extra  |  Company News

Trump blasts Pfizer for price hikes, threatens to respond

President Donald Trump threatened to take action against companies for increasing drug prices in a tweet Monday that specifically named Pfizer Inc. (NYSE:PFE). Trump tweeted, “Pfizer & others should be ashamed that they have raised drug...
03:02 , Jun 30, 2018 |  BioCentury  |  Finance

Smitten by SMID-caps

Risk is pervasive heading into the third quarter and choppy waters are expected, but 13 buysiders told BioCentury they’re not afraid to stay the course. A politically charged environment is likely to intensify as the midterm...